Practice Variation in Acute Bronchiolitis: A Pediatric Emergency Research Networks Study

Author:

Schuh Suzanne123,Babl Franz E.4,Dalziel Stuart R.5,Freedman Stephen B.67,Macias Charles G.8,Stephens Derek2,Steele Dale W.9,Fernandes Ricardo M.10,Zemek Roger11,Plint Amy C.11,Florin Todd A.12,Lyttle Mark D.13,Johnson David W.61415,Gouin Serge16,Schnadower David17,Klassen Terry P.18,Bajaj Lalit19,Benito Javier20,Kharbanda Anupam21,Kuppermann Nathan2223,

Affiliation:

1. Division of Paediatric Emergency Medicine and

2. The Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Ontario, Canada;

3. University of Toronto, Toronto, Ontario, Canada;

4. Emergency Department, Royal Children’s Hospital, Murdoch Children’s Research Institute, and University of Melbourne, Melbourne, Australia;

5. Emergency Department, Starship Children’s Hospital, and University of Auckland, Auckland, New Zealand;

6. Sections of Pediatric Emergency Medicine,

7. Gastroenterology,

8. Pediatric Emergency Medicine, Baylor College of Medicine and Texas Children’s Hospital, Houston, Texas;

9. Section of Pediatric Emergency Medicine, Hasbro Children’s Hospital and Section of Pediatric Emergency Medicine, Rhode Island Hospital, Providence, Rhode Island;

10. Department of Pediatrics, Hospital de Santa Maria and Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, Instituto de Medicina Molecular, University of Lisbon, Lisbon, Portugal;

11. Division of Pediatric Emergency Medicine, University of Ottawa and Children’s Hospital of Eastern Ontario, Ottawa, Ontario, Canada;

12. Division of Emergency Medicine, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio;

13. Pediatric Emergency Department, Bristol Royal Hospital for Children and Faculty of Health and Life Sciences, University of the West of England, Bristol, United Kingdom;

14. Emergency Medicine, and

15. Physiology and Pharmacology, Department of Pediatrics, Alberta Children’s Hospital Research Institute and Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada;

16. Centre hospitalier universitaire Sainte-Justine, University of Montreal, Montreal, Quebec, Canada;

17. Pediatric Emergency Medicine, School of Medicine, Washington University in St Louis, St Louis, Missouri;

18. Manitoba Institute of Child Health, University of Manitoba, Winnipeg, Manitoba, Canada;

19. Department of Pediatrics, Children’s Hospital Colorado, Aurora, Colorado;

20. Pediatric Emergency Department, Cruces University Hospital, Barakaldo, Bizkaia, Spain;

21. Emergency Department, Children’s Hospital of Minnesota, Minneapolis, Minnesota; and

22. Departments of Emergency Medicine and

23. Pediatrics, Davis School of Medicine, University of California, Sacramento, California

Abstract

BACKGROUND AND OBJECTIVES: Studies characterizing hospitalizations in bronchiolitis did not identify patients receiving evidence-based supportive therapies (EBSTs). We aimed to evaluate intersite and internetwork variation in receipt of ≥1 EBSTs during the hospital management of infants diagnosed with bronchiolitis in 38 emergency departments of pediatric emergency research networks in Canada, the United States, Australia, New Zealand, the United Kingdom, Ireland, Spain, and Portugal. We hypothesized that there would be significant variation, adjusted for patient characteristics. METHODS: Retrospective cohort study of previously healthy infants aged <12 months with bronchiolitis. Our primary outcome was that hospitalization occurred with EBST (ie, parenteral fluids, oxygen, or airway support). RESULTS: Out of 3725 participants, 1466 (39%) were hospitalized, and 1023 out of 1466 participants (69.8%) received EBST. The use of EBST varied by site (P < .001; range 6%–99%, median 23%), but not by network (P = .2). Significant multivariable predictors and their odds ratios (ORs) were as follows: age (0.9), oxygen saturation (1.3), apnea (3.4), dehydration (3.2), nasal flaring and/or grunting (2.4), poor feeding (2.1), chest retractions (1.9), and respiratory rate (1.2). The use of pharmacotherapy and radiography varied by network and site (P < .001), with respective intersite ranges 2% to 79% and 1.6% to 81%. Compared with Australia and New Zealand, the multivariable OR for the use of pharmacotherapy in Spain and Portugal was 22.7 (95% confidence interval [CI]: 4.5–111), use in Canada was 11.5 (95% CI: 3.7–36), use in the United States was 6.8 (95% CI: 2.3–19.8), and use in the United Kingdom was 1.4 (95% CI: 0.4–4.2). Compared with United Kingdom, OR for radiography use in the United States was 4.9 (95% CI 2.0–12.2), use in Canada was 4.9 (95% CI 1.9–12.6), use in Spain and Portugal was 2.4 (95% CI 0.6–9.8), and use in Australia and New Zealand was 1.8 (95% CI 0.7–4.7). CONCLUSIONS: More than 30% of infants hospitalized with bronchiolitis received no EBST. The hospital site was a source of variation in all study outcomes, and the network also predicted the use of pharmacotherapy and radiography.

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology and Child Health

Cited by 77 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3